Reyes Arranz, Ana García-Noblejas, Carlos Grande, Jimena Cannata-Ortiz, José J. Sánchez, José-Antonio García-Marco, Concepción Aláez, Javier Pérez-Calvo, Pilar Martínez-Sánchez, Blanca Sánchez-González, Miguel-Angel Canales, Eulogio Conde, Alejandro Martín, Eva Arranz, María-José Terol, Antonio Salar, and Dolores Caballero. 2013. “First-Line Treatment With Rituximab-HyperCVAD Alternating With Rituximab-Methotrexate-Cytarabine and Followed by Consolidation With 90Y-Ibritumomab-Tiuxetan in Patients With Mantle Cell Lymphoma. Results of a Multicenter, Phase 2 Pilot Trial from the GELTAMO Group”. Haematologica 98 (10). Pavia, Italy, 1563-70. https://doi.org/10.3324/haematol.2013.088377.